98%
921
2 minutes
20
Quantitative imaging of alpha-emitting radionuclides is essential for accurate dosimetry in radiopharmaceutical therapy (RPT). This study evaluates the performance of inkjet-deposited Am sources imaged with the ionizing-radiation Quantum Imaging Detector (iQID), focusing on spatial resolution, substrate effects, and activity recovery. Line and areal phantom patterns were printed onto stainless steel, nickel, and gold-coated nickel substrates. Imaging was performed at 10 μm and 20 μm pixel resolutions, with normalization and alignment enabling direct comparisons. The iQID system successfully resolved printed features at 10 μm, and gold-coated nickel consistently exhibited the most confined and uniform deposition. Bitmap-based areal sources showed greater variability due to fluctuations in droplet frequency and inconsistent mass delivery. While iQID input settings influenced count rate, resolution remained largely stable across configurations. This study demonstrates the utility of combining precision inkjet printing with digital autoradiography for fabricating and characterizing high-resolution alpha-emitting sources, laying the groundwork for improved phantom development and dosimetric validation in RPT applications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.apradiso.2025.112108 | DOI Listing |
Appl Radiat Isot
August 2025
Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Quantitative imaging of alpha-emitting radionuclides is essential for accurate dosimetry in radiopharmaceutical therapy (RPT). This study evaluates the performance of inkjet-deposited Am sources imaged with the ionizing-radiation Quantum Imaging Detector (iQID), focusing on spatial resolution, substrate effects, and activity recovery. Line and areal phantom patterns were printed onto stainless steel, nickel, and gold-coated nickel substrates.
View Article and Find Full Text PDFSci Rep
August 2025
Mallinckrodt Institute of Radiology, University of Washington in St. Louis School of Medicine, St. Louis, MO, USA.
Alpha-emitter radiopharmaceutical therapy delivers highly localized radiation, offering potent therapeutic effects. However, microscale heterogeneity remains poorly characterized in vivo and may affect efficacy. This underscores the critical need for sub-organ dosimetry to better understand αRPT radiobiology and guide treatment optimization.
View Article and Find Full Text PDFAnal Chim Acta
August 2025
European Commission - Joint Research Centre Karlsruhe, P.O. Box 2340, D-76125, Karlsruhe, Germany.
Background: Assessing uranium (U) enrichment levels in uranium dioxide (UO) pellets is critical for nuclear forensics and ensuring compliance with non-proliferation policies. This study presents a novel analytical method utilising digital autoradiography with a commercial imaging plate scanner to enhance the assessment of U enrichment levels. By comparing various imaging plates and exposure times, the study aims to establish optimal conditions for measurement accuracy and reproducibility.
View Article and Find Full Text PDFCommun Eng
May 2025
Molecular Imaging Branch, National Cancer Institute, Bethesda, MD, USA.
Autoradiography is used to study the distribution and binding of radioisotope tagged ligands in tissue at microscale among other applications. The technology has evolved since its inception when it used analogue film exposure techniques with the introduction of digital imaging systems sensitive to ionizing radiation. We report on the development of our Quantitative Particle Identification spectral autoradiography system (QPID), which is based on the Timepix3 sensor and a gamma detecting scintillation crystal.
View Article and Find Full Text PDFMol Diagn Ther
July 2025
Department of Biomedicine and Prevention, University Tor Vergata, Via Montpellier 1, 0133, Rome, Italy.
Post-ischemic myocardial remodeling significantly impacts clinical outcomes after acute myocardial infarction (MI), involving structural and functional changes such as ventricular dilation, infarct wall thinning, and fibrosis development. These processes, driven by inflammatory cascades, neurohormonal activation, and extracellular matrix remodeling, result in impaired cardiac output and an increased risk of heart failure. Imaging with fibroblast activation protein inhibitors (FAPI) has emerged as a promising non-invasive tool for assessing myocardial fibrosis via positron emission tomography (PET) or single-photon emission computed tomography (SPECT), targeting activated fibroblasts; the mediators of reparative and fibrotic processes.
View Article and Find Full Text PDF